Published in Gut on February 01, 1976
Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis. Br J Clin Pharmacol (2001) 1.15
Intravenous propranolol in patients with inflammation. Br J Clin Pharmacol (1982) 1.02
Effect of age on plasma propranolol levels. Br J Clin Pharmacol (1980) 0.98
Influence of cimetidine on pharmacokinetics of propranolol. Br Med J (Clin Res Ed) (1981) 0.75
Plasma propranolol levels in Crohn's disease and coeliac disease. Br Med J (1977) 0.75
The absorption and conjugation of methyldopa in patients with coeliac and Crohn's diseases during treatment. Br J Clin Pharmacol (1983) 0.75
Study of the bioavailability of pindolol in malabsorption syndromes. Br J Clin Pharmacol (1984) 0.75
Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther (1970) 9.54
On the mechanism of intestinal absorption of drugs. J Pharmacol Exp Ther (1959) 3.16
The disposition of propranolol. I. Elimination during oral absorption in man. Pharmacology (1972) 2.50
Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey. J Pharmacol Exp Ther (1971) 2.34
The effect of age on plasma levels of propranolol and practolol in man. Br J Clin Pharmacol (1975) 2.28
KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG. J Pharm Sci (1964) 2.19
Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man. Clin Pharmacol Ther (1973) 2.14
Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs. Drugs (1974) 1.46
A comparison of the effects of propranolol and practolol on forced expiratory volume and resting heart rate in normal subjects. Arch Int Pharmacodyn Ther (1971) 1.45
Intraluminal pH of duodenum and jejunum in fasting subjects with normal and abnormal gastric or pancreatic function. Scand J Gastroenterol (1971) 1.39
The absorption of antibiotics in adult patients with coeliac disease. J Antimicrob Chemother (1975) 1.24
Proceedings: The influence of urine pH on the renal excretion of practolol and propranolol. Br J Pharmacol (1973) 1.20
Gastric emptying in healthy subjects and in patients with various malabsorptive states. Scand J Gastroenterol (1974) 1.16
Effects of atropine on heart-rate in healthy man. Lancet (1967) 5.10
Effect of homeopathic treatment on fibrositis (primary fibromyalgia) BMJ (1989) 5.00
Localization of the human alpha-globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay. Cell (1977) 4.34
The effects of a new beta-adrenoceptive receptor blocking drug on heart rate in man. Br J Pharmacol Chemother (1968) 3.95
Mucosal adherence of human enteropathogenic Escherichia coli. Lancet (1975) 3.54
The effect of propranolol on anxiety. Lancet (1966) 3.33
The Radical Cure of Inguinal Hernia in Children. Proc R Soc Med (1912) 3.29
Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man. Br J Pharmacol (1969) 3.25
Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med (1994) 2.80
Differences in human alpha-, beta- and delta-globin gene expression in monkey kidney cells. Cell (1982) 2.78
Chromosomal localization of human beta globin gene on human chromosome 11 in somatic cell hybrids. Proc Natl Acad Sci U S A (1978) 2.65
Factors in the inactivation of postjunctional membrane receptors of frog skeletal muscle. J Gen Physiol (1970) 2.52
Sensitive method for the routine determination tricyclic antidepressants in plasma using a specific nitrogen detector. J Chromatogr (1975) 2.48
Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome. Br Med J (1966) 2.31
Studies of the interaction of desmethylimipramine with tyramine in man after a single oral dose, and its correlation with plasma concentration. Br J Clin Pharmacol (1976) 2.29
The effect of age on plasma levels of propranolol and practolol in man. Br J Clin Pharmacol (1975) 2.28
The socioemotional development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry (1999) 2.23
Plasma concentrations of fenfluramine and its metabolite, norfenfluramine, after single and repeated oral administration. Br J Pharmacol (1971) 2.23
The severity of asthma in relation to beta agonist prescribing. N Z Med J (1991) 2.20
A maize zinc-finger protein binds the prolamin box in zein gene promoters and interacts with the basic leucine zipper transcriptional activator Opaque2. Proc Natl Acad Sci U S A (1997) 2.19
Talking about drugs - the role of the clinical pharmacologist. J R Soc Med (1982) 2.15
Cardiac and pulmonary effects of acebutolol. Lancet (1975) 2.12
Functional analysis of the transcription control region located within the avian retroviral long terminal repeat. Mol Cell Biol (1985) 2.12
The interactions of local guanethidine and sympathomimetic amines in the human eye. Arch Ophthalmol (1969) 2.09
Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state. Lancet (1965) 2.09
Critical flicker frequency and centrally-acting drugs. Br J Ophthalmol (1968) 2.08
Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise. Br J Clin Pharmacol (1978) 2.07
A simple method to measure drug effects on human sperm motility. Br J Clin Pharmacol (1981) 2.06
New approach to assessment of cardioselectivity of beta-blocking drugs. Br Med J (1974) 2.06
An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man. Br J Clin Pharmacol (1975) 2.05
Adrenergic blockade and the eye signs of thyrotoxicosis. Lancet (1966) 2.02
Relative potencies of sympathetic amines in human smooth muscle. Br J Pharmacol (1969) 1.98
Influence of chronic dosing on theophylline clearance. Br J Clin Pharmacol (1984) 1.98
Intravenous tyramine pressor response in depression. Lancet (1975) 1.98
Immunological aspects of candida infection complicating steroid and immunosuppressive drug therapy. Lancet (1970) 1.96
Some central and peripheral effects of meclastine, a new antihistaminic drug, in man. J Clin Pharmacol New Drugs (1971) 1.94
Action of fenfluramine on isolated human smooth muscle. Lancet (1969) 1.94
The inhibitory action of procaine, (+)-propranolol and (+/-)-propranolol on human sperm motility: antagonism by caffeine. Br J Clin Pharmacol (1981) 1.88
Written information given to patients and families by palliative care units: a national survey. Lancet (2000) 1.88
Some clinical pharmacological studies with terfenadine, a new antihistamine drug. Br J Clin Pharmacol (1978) 1.86
The bioavailability of quinine. J Trop Med Hyg (1976) 1.80
Class experiment in clinical pharmacology with benzilonium bromide, an anticholinergic drug. Eur J Clin Pharmacol (1974) 1.72
International trial of long-term dexfenfluramine in obesity. Lancet (1989) 1.70
A comparison of the effects of chlorphentermine, diethylpropion and phenmetrazine on critical flicker frequency. Br J Pharmacol Chemother (1967) 1.70
Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer (1996) 1.70
Prescription of benzodiazepines in a London teaching hospital. J R Soc Med (1990) 1.69
Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illness. Psychopharmacology (Berl) (1976) 1.68
Transcriptional activity of avian retroviral long terminal repeats directly correlates with enhancer activity. J Virol (1985) 1.67
Active conformation of the globin genes in uninduced and induced mouse erythroleukemia cells. Cell (1978) 1.64
Selective pharmacological inhibition of lymphocyte stimulation. Lancet (1971) 1.62
Alpha receptor blockade by thymoxamine in the human eye. Clin Pharmacol Ther (1968) 1.60
Voltage clamp study of fast excitatory synaptic currents in bullfrog sympathetic ganglion cells. J Gen Physiol (1980) 1.59
Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis. Gut (1982) 1.59
Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochem Biophys Res Commun (2000) 1.59
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Bile duct injury during laparoscopic cholecystectomy: a report of the Standards Sub-committee of the Victorian State Committee of the Royal Australasian College of Surgeons. Aust N Z J Surg (1993) 1.53
Characteristics of the acetylcholine-operated channel at twitch and slow fibre neuromuscular junctions of the garter snake. J Physiol (1981) 1.51
The Treatment of a Denture, Swallowed and Impacted in the OEsophagus, by means of Killian's OEsophageal Tube. Proc R Soc Med (1909) 1.51
Explanation for potency of repeated oral doses of morphine? Lancet (1987) 1.47
Proceedings: Effect of fenfluramine and norfenfluramine on glucose uptake by the isolated rat diaphragm. Br J Pharmacol (1974) 1.46
A comparison of the effects of propranolol and practolol on forced expiratory volume and resting heart rate in normal subjects. Arch Int Pharmacodyn Ther (1971) 1.45
Intravenous treatment with rimiterol and salbutamol in asthma. Br Med J (1975) 1.45
Chlortenoxicam pharmacokinetics in young and elderly human volunteers. Postgrad Med J (1988) 1.45
Influence of lanthanum on transmitter release at the neuromuscular junction. J Neurobiol (1971) 1.42
Analgesic effects of oral flecainide. Lancet (1988) 1.41
Absorption of two antibacterial drugs, cephalexin and co-trimoxazole, in malabsorption syndromes. J Antimicrob Chemother (1975) 1.41
Holliday junctions in FLP recombination: resolution by step-arrest mutants of FLP protein. Proc Natl Acad Sci U S A (1988) 1.40
A comparison of three beta-adrenergic receptor-blocking drugs in thyrotoxic tachycardia. J Clin Pharmacol J New Drugs (1968) 1.40
Sulfasalazine interference in total protein measurement on the Beckman CX7. Clin Chem (1993) 1.39
Local formularies and good patient care. Br Med J (Clin Res Ed) (1984) 1.39
A rapid and specific semi-micro method involving high-pressure liquid chromatography for the assay of metronidazole in plasma, saliva, serum, urine and whole blood. Br J Clin Pharmacol (1980) 1.38
The narcotic equivalency index. World Health Forum (1989) 1.38
Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions. Postgrad Med J (1985) 1.38
The effects of high doses of oxprenolol and of propranolol on pursuit rotor performance, reaction time and critical flicker frequency. Psychopharmacologia (1976) 1.38
Effect of promethazine hydrochloride on hand-eye co-ordination. Nature (1966) 1.38
Beta-adrenergic-receptor blockade with practolol in treatment of anxiety. Lancet (1972) 1.37
Aspartame pharmacokinetics - the effect of ageing. Age Ageing (1996) 1.37
Changes in gut flora after cephalexin treatment. Br Med J (1970) 1.37
Relative stability of alpha- and beta-globin messenger RNAs in homozygous beta+ thalassemia. Proc Natl Acad Sci U S A (1977) 1.36
Desensitization onset and recovery at the potassium-depolarized frog neuromuscular junction are voltage sensitive. J Gen Physiol (1978) 1.36
Bromocriptine eyedrops lower intraocular pressure without affecting prolactin levels. Lancet (1984) 1.34
Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J Clin Invest (1987) 1.33
Current status of clinical pharmacology in the United Kingdom. Clin Pharmacol Ther (1986) 1.32
Acebutolol: ten years of experience. Am Heart J (1985) 1.31
Acute haemodynamic effects of a new calcium antagonist, nicardipine, in man. A comparison with nifedipine. Br J Clin Pharmacol (1983) 1.30
Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs. Br J Clin Pharmacol (1978) 1.29
Influence of disease on drug toxicity. Arch Toxicol Suppl (1984) 1.29
Plasma uptake of dopamine and 5-hydroxytryptamine and plasma-catecholamine levels in patients with Huntington's chorea. Lancet (1974) 1.27
Influence of polyvalent cations on the activation of muscle end plate receptors. J Gen Physiol (1970) 1.27
Identification of the active site tyrosine of Flp recombinase. Possible relevance of its location to the mechanism of recombination. J Biol Chem (1990) 1.27
Bromocriptine lowers intraocular pressure without affecting blood pressure. Lancet (1983) 1.26
Preliminary studies on the central effects of lorazepam, a new benzodiazepine. J Clin Pharmacol New Drugs (1972) 1.26
Stimulation of dopamine receptors (type 2) lowers human intraocular pressure. Br J Ophthalmol (1985) 1.26
Desensitization and recovery at the frog neuromuscular junction. J Gen Physiol (1977) 1.26
Clinical pharmacology and general patient care in two teaching hospitals. J R Soc Med (1980) 1.25